Headquartered in Northfield, IL Fiscal year ends December NASDAQ: MDLN medline.com
Medline Inc. (Nasdaq: MDLN) describes itself as the largest provider of medical-surgical products and supply chain solutions serving all points of care, including hospitals and other healthcare providers. It operates two reporting segments:
- **Medline Brand:** its own manufactured and sourced med-surg products, including kitting, which carries higher margins.
- **Supply Chain Solutions:** distribution of third-party products through Prime Vendor relationships and its distribution network, which carries lower margins.
Medline relies on Group Purchasing Organizations and large healthcare provider customers. It employs more than 45,000 people and operates in more than 100 countries.
The company went public via an IPO and operates under an Up-C structure with Class A and Class B shares and Medline Holdings, LP units. That structure gives rise to noncontrolling interests and a tax receivable agreement liability.
Recent developments include:
- IEEPA tariff refunds following a February 2026 U.S. Supreme Court ruling
- a fire at its Tracy, California distribution center
- FDA remediation and quality initiatives
- investment in distribution automation and new distribution centers
- debt reduction
- a new $1 billion share repurchase program Updated
Medline raised its full-year organic sales growth outlook to 10.0%-10.5% from 9.0%-10.0% after beating EPS expectations by 27%. $81 million of net IEEPA tariff refund benefits landed in the quarter while gross margin narrowed to 24.5% from 26.4% a year earlier.
Pre-Market Stock Futures: Futures are trading lower as we hit the mid-point of the trading week, and while we didn’t see the snapback rally that was the star of the show Monday,…
Pre-Market Stock Futures: The futures are trading lower on Monday morning after a strong finish to the week on Friday, completing a winning week for investors as all three of the major…
Kodiak Sciences, Medline, and W.R. Berkley have seen some huge insider purchases, and there were some other notable insider purchases as well..
Medline Inc. (Nasdaq: MDLN) describes itself as the largest provider of medical-surgical products and supply chain solutions serving all points of care, including hospitals and other healthcare providers.
The Wall Street consensus 12-month price target for MDLN is $45.31.
